Legal & General Group Plc - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$29,607
+26.4%
6,194
+12.4%
0.00%
Q2 2023$23,418
-43.2%
5,510
-29.0%
0.00%
Q1 2023$41,200
-63.9%
7,759
-57.4%
0.00%
Q4 2022$114,271
-39.2%
18,196
+2.4%
0.00%
Q3 2022$188,000
+111.2%
17,767
+7.9%
0.00%
Q2 2022$89,000
-13.6%
16,473
+46.6%
0.00%
Q1 2022$103,000
-16.3%
11,233
+37.8%
0.00%
Q4 2021$123,000
+186.0%
8,153
+353.4%
0.00%
Q3 2021$43,0001,7980.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$6,189,0007.17%
72 Investment Holdings, LLC 474,067$4,352,0004.76%
Velan Capital Investment Management LP 210,695$1,934,0001.80%
PFM Health Sciences, LP 4,370,545$40,122,0001.50%
Monashee Investment Management LLC 470,000$4,315,0001.25%
Avidity Partners Management LP 2,819,067$25,879,0000.54%
Rokos Capital Management LLP 849,334$7,899,0000.37%
Green Alpha Advisors, LLC 49,674$456,0000.31%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 181,304$1,664,0000.25%
Tekla Capital Management LLC 699,377$6,420,0000.22%
View complete list of CARIBOU BIOSCIENCES INC shareholders